These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 32345060)
1. Health utility estimation in children and adolescents: a review of health technology assessments. Bégo-Le Bagousse G; Jia X; Wolowacz S; Eckert L; Tavi J; Hudson R Curr Med Res Opin; 2020 Jul; 36(7):1209-1224. PubMed ID: 32345060 [No Abstract] [Full Text] [Related]
2. A Review of the Methods Used to Generate Utility Values in NICE Technology Assessments for Children and Adolescents. Hill H; Rowen D; Pennington B; Wong R; Wailoo A Value Health; 2020 Jul; 23(7):907-917. PubMed ID: 32762993 [TBL] [Abstract][Full Text] [Related]
3. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Griebsch I; Coast J; Brown J Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026 [TBL] [Abstract][Full Text] [Related]
4. Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Longworth L; Rowen D Value Health; 2013; 16(1):202-10. PubMed ID: 23337232 [TBL] [Abstract][Full Text] [Related]
5. What value health?: A review of health state values used in early technology assessments for NICE. Stein K; Fry A; Round A; Milne R; Brazier J Appl Health Econ Health Policy; 2005; 4(4):219-28. PubMed ID: 16466273 [TBL] [Abstract][Full Text] [Related]
6. Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies. Dundar Y; Dodd S; Dickson R; Walley T; Haycox A; Williamson PR Health Technol Assess; 2006 Feb; 10(5):iii-iv, ix-145. PubMed ID: 16487455 [TBL] [Abstract][Full Text] [Related]
7. HEALTH TECHNOLOGY ASSESSMENTS REPORTING COST-EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE IMPLANTATION. Kularatna S; Byrnes J; Mervin MC; Scuffham PA Int J Technol Assess Health Care; 2016 Jan; 32(3):89-96. PubMed ID: 27491522 [TBL] [Abstract][Full Text] [Related]
8. Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review. Herdman M; Cole A; Hoyle CK; Coles V; Carroll S; Devlin N Value Health; 2016; 19(2):255-66. PubMed ID: 27021761 [TBL] [Abstract][Full Text] [Related]
9. Trends in the measurement of health utilities in published cost-utility analyses. Brauer CA; Rosen AB; Greenberg D; Neumann PJ Value Health; 2006; 9(4):213-8. PubMed ID: 16903990 [TBL] [Abstract][Full Text] [Related]
10. Are adverse effects incorporated in economic models? An initial review of current practice. Craig D; McDaid C; Fonseca T; Stock C; Duffy S; Woolacott N Health Technol Assess; 2009 Dec; 13(62):1-71, 97-181, iii. PubMed ID: 20018146 [TBL] [Abstract][Full Text] [Related]
11. A preliminary survey on the influence of rapid health technology assessments. Hailey D Int J Technol Assess Health Care; 2009 Jul; 25(3):415-8. PubMed ID: 19619362 [TBL] [Abstract][Full Text] [Related]
12. Inclusion of Carer Health-Related Quality of Life in National Institute for Health and Care Excellence Appraisals. Pennington BM Value Health; 2020 Oct; 23(10):1349-1357. PubMed ID: 33032779 [TBL] [Abstract][Full Text] [Related]
13. Development of stakeholder-informed recommendations for inclusion of family spillover effects in health technology assessment. Campbell DJ; Pandey R; Bloudek LM; Carlson JJ; Wallick C; Veenstra DL; Kowal S J Manag Care Spec Pharm; 2024 Sep; 30(9):1013-1024. PubMed ID: 39213143 [TBL] [Abstract][Full Text] [Related]
14. The prevalence of child-specific utilities in NICE appraisals for paediatric indications: rise of the economic orphans? Montgomery SM; Kusel J Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):347-50. PubMed ID: 27082293 [TBL] [Abstract][Full Text] [Related]
15. Do the findings of case series studies vary significantly according to methodological characteristics? Dalziel K; Round A; Stein K; Garside R; Castelnuovo E; Payne L Health Technol Assess; 2005 Jan; 9(2):iii-iv, 1-146. PubMed ID: 15588556 [TBL] [Abstract][Full Text] [Related]
16. Health technology assessment of public health interventions: an analysis of characteristics and comparison of methods-study protocol. Mathes T; Willms G; Polus S; Stegbauer C; Messer M; Klingler C; Ehrenreich H; Niebuhr D; Marckmann G; Gerhardus A; Pieper D Syst Rev; 2018 May; 7(1):79. PubMed ID: 29792224 [TBL] [Abstract][Full Text] [Related]
17. The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment. Grimm SE; Strong M; Brennan A; Wailoo AJ Pharmacoeconomics; 2017 Dec; 35(12):1287-1296. PubMed ID: 28849538 [TBL] [Abstract][Full Text] [Related]
18. A review of preference-based measures for the assessment of quality of life in children and adolescents with cerebral palsy. Mpundu-Kaambwa C; Chen G; Huynh E; Russo R; Ratcliffe J Qual Life Res; 2018 Jul; 27(7):1781-1799. PubMed ID: 29569017 [TBL] [Abstract][Full Text] [Related]
19. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314 [TBL] [Abstract][Full Text] [Related]
20. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions. Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]